drugset / Trial / NCT01544504
Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy
Phase 1/2
Withdrawn
ProCertus BioPharm, Inc
H. Lee Moffitt Cancer Center and Research Institute · collab
NaSingle-groupOpen-labelPrevention
Summary
This study, a nonrandomized open-label safety and exploratory study, will evaluate the safety of topical norepinephrine in post-surgical breast cancer patients who are undergoing radiation therapy. The study will also provide information about whether topical norepinephrine can prevent or decrease the severity of the radiation dermatitis experienced by these patients.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norepinephrine | Other / unclassified | 4.65 ml | Topical |
| Subject | Norepinephrine | Other / unclassified | 82.3 mg/ml | Topical |